Merck’s Vioxx replacement is off to a bad start.
…
"The development program for Arcoxia is fatally flawed"
ADVERTISEMENT
More in Uncategorized
Past Week
-
Alex Pretti: a physician’s open letter defending his legacy
-
The elephant in the room: Why physician burnout is a relationship problem
-
ADHD and cannabis use: Navigating the diagnostic challenge
-
AI-enabled clinical data abstraction: a nurse’s perspective
-
Why private equity is betting on employer DPC over retail
-
Leading with love: a physician’s guide to clarity and compassion
-
Past 6 Months
-
Physician on-call compensation: the unpaid labor driving burnout
-
How environmental justice and health disparities connect to climate change
-
Will AI replace primary care physicians?
-
A physician father on the Dobbs decision and reproductive rights
-
What is the minority tax in medicine?
-
Why the U.S. health care system is failing patients and physicians
-
Recent Posts
-
Nervous system dysregulation vs. stress: Why “just relaxing” doesn’t work
-
U.S. opioid policy history: How politics replaced science in pain care
-
Alex Pretti’s death: Why politics belongs in emergency medicine
-
Women in health care leadership: Navigating competition and mentorship
-
Senior financial scams: a guide for primary care physicians
-
Moral courage in medical training: the power of the powerless
-
Subscribe to KevinMD and never miss a story!
Get free updates delivered free to your inbox.
